355 related articles for article (PubMed ID: 23975266)
1. Alterations of DNA methylome in human bladder cancer.
Besaratinia A; Cockburn M; Tommasi S
Epigenetics; 2013 Oct; 8(10):1013-22. PubMed ID: 23975266
[TBL] [Abstract][Full Text] [Related]
2. A Versatile Assay for Detection of Aberrant DNA Methylation in Bladder Cancer.
Tommasi S; Besaratinia A
Methods Mol Biol; 2018; 1655():29-41. PubMed ID: 28889375
[TBL] [Abstract][Full Text] [Related]
3. Genotoxicity of tobacco smoke-derived aromatic amines and bladder cancer: current state of knowledge and future research directions.
Besaratinia A; Tommasi S
FASEB J; 2013 Jun; 27(6):2090-100. PubMed ID: 23449930
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics of human melanoma: promises and challenges.
Besaratinia A; Tommasi S
J Mol Cell Biol; 2014 Oct; 6(5):356-67. PubMed ID: 24895357
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection.
Negraes PD; Favaro FP; Camargo JL; Oliveira ML; Goldberg J; Rainho CA; Salvadori DM
BMC Cancer; 2008 Aug; 8():238. PubMed ID: 18702824
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation.
Reinert T; Borre M; Christiansen A; Hermann GG; Ørntoft TF; Dyrskjøt L
PLoS One; 2012; 7(10):e46297. PubMed ID: 23056278
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic biomarkers for early detection, therapeutic effectiveness and relapse monitoring in bladder cancer.
Dumache R; David D; Kaycsa A; Minciu R; Negru S; Puiu M
Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):163-7. PubMed ID: 21682190
[TBL] [Abstract][Full Text] [Related]
8. [Characterisation of DNA methylation biomarkers for bladder cancer].
Antony P; Rose M; Gaisa NT; Alkaya S; Heidenreich A; Knüchel R; Dahl E
Pathologe; 2010 Oct; 31 Suppl 2():244-50. PubMed ID: 20798943
[TBL] [Abstract][Full Text] [Related]
9. Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling.
van der Kwast TH; Bapat B
Curr Opin Urol; 2009 Sep; 19(5):516-21. PubMed ID: 19553819
[TBL] [Abstract][Full Text] [Related]
10. Prognostic DNA Methylation Biomarkers in High-risk Non-muscle-invasive Bladder Cancer: A Systematic Review to Identify Loci for Prospective Validation.
Gurung PMS; Barnett AR; Wilson JS; Hudson J; Ward DG; Messing EM; Bryan RT
Eur Urol Focus; 2020 Jul; 6(4):683-697. PubMed ID: 30803927
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics application in the diagnosis and treatment of bladder cancer.
Harb-de la Rosa A; Acker M; Kumar RA; Manoharan M
Can J Urol; 2015 Oct; 22(5):7947-51. PubMed ID: 26432963
[TBL] [Abstract][Full Text] [Related]
12. The Bladder EpiCheck Test as a Non-Invasive Tool Based on the Identification of DNA Methylation in Bladder Cancer Cells in the Urine: A Review of Published Evidence.
Mancini M; Righetto M; Zumerle S; Montopoli M; Zattoni F
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911596
[TBL] [Abstract][Full Text] [Related]
13. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Alterations in Bladder Cancer.
Porten SP
Curr Urol Rep; 2018 Oct; 19(12):102. PubMed ID: 30357502
[TBL] [Abstract][Full Text] [Related]
15. Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancer.
Shivakumar M; Lee Y; Bang L; Garg T; Sohn KA; Kim D
BMC Med Genomics; 2017 May; 10(Suppl 1):30. PubMed ID: 28589857
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics of kidney cancer and bladder cancer.
Hoffman AM; Cairns P
Epigenomics; 2011 Feb; 3(1):19-34. PubMed ID: 22126150
[TBL] [Abstract][Full Text] [Related]
17. Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?
Kim YJ; Kim WJ
Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S77-88. PubMed ID: 27326410
[TBL] [Abstract][Full Text] [Related]
18. Mediation by differential DNA methylation of known associations between single nucleotide polymorphisms and bladder cancer risk.
Jordahl KM; Phipps AI; Randolph TW; Tinker LF; Nassir R; Hou L; Anderson GL; Kelsey KT; White E; Bhatti P
BMC Med Genet; 2020 Nov; 21(1):228. PubMed ID: 33213418
[TBL] [Abstract][Full Text] [Related]
19. Epigenetics in bladder cancer.
Enokida H; Nakagawa M
Int J Clin Oncol; 2008 Aug; 13(4):298-307. PubMed ID: 18704629
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic alterations of adenomatous polyposis coli (APC), retinoic acid receptor beta (RARβ) and survivin genes in tumor tissues and voided urine of bladder cancer patients.
Berrada N; Amzazi S; Ameziane El Hassani R; Benbacer L; El Mzibri M; Khyatti M; Chafiki J; Abbar M; Al Bouzidi A; Ameur A; Attaleb M
Cell Mol Biol (Noisy-le-grand); 2012 Sep; Suppl.58():OL1744-51. PubMed ID: 22992440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
